Line 41: | Line 41: | ||
<h1>Cell-free Synthesis Components</h1> | <h1>Cell-free Synthesis Components</h1> | ||
+ | |||
+ | <li> 15 parts improved from our N<i>ex</i>t <i>vivo</i> project. </li> | ||
+ | <li> Our goal with these parts was to continue standardizing, improving and simplifying our protocols.</li> | ||
+ | <li> Beginning design of Cell Free PNC Synthesis.</li> | ||
<img src="https://static.igem.org/mediawiki/2018/6/6e/T--Lethbridge--next_vivo.png"> | <img src="https://static.igem.org/mediawiki/2018/6/6e/T--Lethbridge--next_vivo.png"> |
Revision as of 08:03, 17 October 2018
![Main Page Banner](https://static.igem.org/mediawiki/2018/9/97/T--Lethbridge--banner_MainPage.png)
VINCEnT: Viral-Inspired Novel Cargo Encapsulation Toolkit
Protein Nanocompartments
![](https://static.igem.org/mediawiki/2018/e/e9/T--Lethbridge--vincentFace.png)
Software
![](https://static.igem.org/mediawiki/2018/6/60/T--Lethbridge--computer_vincent.png)
Risk Assessment Rubric
![](https://static.igem.org/mediawiki/2018/2/20/T--Lethbridge--law_vincent.png)
Cell-free Synthesis Components
![](https://static.igem.org/mediawiki/2018/6/6e/T--Lethbridge--next_vivo.png)